developing lsc-targeting agents in aml: progress and current therapeutic capacity
Published 3 months ago • 117 plays • Length 0:59Download video MP4
Download video MP3
Similar videos
-
1:49
targeting leukemic stem cells in aml
-
0:57
novel therapeutic strategies in all
-
1:32
the importance of cytogenetics and molecular profiling for accurate aml/mds diagnosis
-
2:26
insights into the future of aml therapy: the increasing use of targeted agents
-
3:47
the impact of cytogenetic-risk stratification on aml outcomes
-
1:27
incorporating new technologies into the real-life classification of aml to guide treatment decisions
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
3:16
acute myeloid leukaemia: everything you need to know
-
5:09
what do you see as the future of aml treatments? #aml
-
8:34
hct in mds: cell source and conditioning type
-
5:25
how the aml treatment landscape is changing with the introduction of novel targeted agents
-
4:45
phase ib/ii multi-arm study of combinations of novel agents in r/r aml
-
1:29
the current landscape of maintenace therapy in aml and areas for future exploration
-
3:44
aml: novel conditioning and maintenance strategies
-
2:02
rwd from insight-mm: duration of therapy and treatment sequencing
-
2:38
session highlights: transforming aml treatment and building on new approaches
-
1:02
the impact of sequencing in aml
-
1:19
astx727 a molecularly-targeted agent as personalized maintenance therapy in patients with aml
-
2:09
advances in the management of fit adults with aml
-
1:36
targeted therapy for aml
-
2:11
the current role of immuno-oncology in aml and future outlooks